Journal article
Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG–positive NMOSD
- Abstract:
- OBJECTIVE:To define the frequency, duration, and severity of intractable nausea, vomiting, or hiccups in aquaporin-4-immunoglobulin G (AQP4-IgG)-positive neuromyelitis optica spectrum disorder (NMOSD) and propose diagnostic criteria and a severity scale for area postrema syndrome (APS). METHODS:An International NMOSD database was interrogated for frequency of APS. Patients with AQP4-IgG-positive NMOSD completed an APS symptom questionnaire. Nausea and vomiting severity was derived from the Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) score. The diagnostic criteria, severity scale, and immunotherapy response was applied to a prospective validation cohort of patients from multiple centers. RESULTS:Analysis of an international database for AQP4-IgG-seropositive NMOSD (n = 430) revealed a high prevalence of isolated APS attacks (onset 7.1%-10.3%; subsequent 9.4%-14.5%) across continents. For 100 patients with 157 episodes of APS, nausea (n = 127, 81%) lasted for a median of 14 days (range 2-365), vomiting (113, 72%) with a median of 5 episodes/d (2-40) lasted 1-20 minutes, and hiccups (102, 65%) lasted a median of 14 days (2-365). Symptoms consistently and completely resolved following immunotherapy. Data were used to propose APS diagnostic criteria and repurpose PUQE score (hiccups severity grade based on symptom duration). The clinical utility was demonstrated in a prospective validation cohort. CONCLUSION:Isolated APS attacks are frequently encountered both at onset and during the NMOSD course. The diagnostic criteria proposed here will assist clinicians in recognizing APS. Diagnosis of an APS attack earlier than 48 hours is possible if a dorsal medulla lesion is detected. Accurate diagnosis and evaluation of APS attack severity will assist in outcome measurement in NMOSD clinical trials.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 614.4KB, Terms of use)
-
- Publisher copy:
- 10.1212/WNL.0000000000006392
Authors
- Publisher:
- American Academy of Neurology
- Journal:
- Neurology More from this journal
- Volume:
- 91
- Issue:
- 17
- Pages:
- e1642-e1651
- Publication date:
- 2018-09-26
- Acceptance date:
- 2018-07-18
- DOI:
- EISSN:
-
1526-632X
- ISSN:
-
0028-3878
- Pmid:
-
30258024
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:923976
- UUID:
-
uuid:04308b09-22b6-44bf-baef-e6011c816aa5
- Local pid:
-
pubs:923976
- Source identifiers:
-
923976
- Deposit date:
-
2019-10-07
- ARK identifier:
Terms of use
- Copyright date:
- 2018
- Notes:
-
Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading
and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
If you are the owner of this record, you can report an update to it here: Report update to this record